Gilstrap James C

Avg. Two Year Performance

(84%) Avg. Purchase Return
(36%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%(8%)(12%)(28%)(84%)
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

VIA Pharmaceuticals, Inc.

Drugs » Biotechnology

Director:

Holdings: 83.33K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--